City Therapeutics is engineering RNAi-based medicines and building a diversified research and development pipeline. Reporting directly to the Chief Medical Officer, the Vice President of Drug Safety and Pharmacovigilance will serve as the company’s senior physician safety expert and provide strategic leadership across pharmacovigilance and drug safety activities. The role is responsible for the global safety strategy, governance, surveillance, reporting, and risk-management capabilities across the clinical-stage portfolio. The Vice President will provide medical oversight of safety data, lead benefit-risk assessments, and ensure scalable, compliant, inspection-ready pharmacovigilance systems. The role partners closely with Clinical Development, Clinical Operations, Regulatory Affairs, Biometrics, Quality, Research, and external partners, combining strategic leadership with hands-on execution. The position is onsite five days per week at City Therapeutics’ Kendall Square offices. The company describes its working model as designed to foster connection, fairness, and growth, and says it is flexible and supportive when individual needs arise. The role is eligible for an annual bonus, equity compensation, and a competitive benefits package. The stated base salary range is $385,000–$405,000.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree